Tag

Medical Research

All articles tagged with #medical research

The evolving role of testosterone in prostate health

Originally Published 18 days ago — by The Conversation

Featured image for The evolving role of testosterone in prostate health
Source: The Conversation

Recent research has challenged the long-held belief that testosterone promotes prostate cancer growth, showing that testosterone therapy is safe for men with low levels and may even help in managing prostate cancer, leading to a shift in medical practice and treatment approaches.

Trump's Executive Order on Marijuana Reclassification and Its Impact on States and Medical Research

Originally Published 23 days ago — by ABC News

Featured image for Trump's Executive Order on Marijuana Reclassification and Its Impact on States and Medical Research
Source: ABC News

President Trump signed an executive order reclassifying marijuana from Schedule I to Schedule III, potentially easing research restrictions and reducing stigma, though it does not legalize the drug federally. Experts believe this change could facilitate more scientific studies on marijuana's medical benefits, but some caution about increased addiction risks and emphasize that marijuana's medicinal value remains unproven by conclusive research.

Trump's Marijuana Reclassification Sparks Uncertainty for Michigan Businesses

Originally Published 24 days ago — by Financial Times

Featured image for Trump's Marijuana Reclassification Sparks Uncertainty for Michigan Businesses
Source: Financial Times

Marijuana stocks fell sharply after President Trump signed an executive order to reclassify marijuana as a less dangerous drug suitable for medical use, but stopped short of full legalization, making it a symbolic win for the industry without changing federal law or impacting markets significantly.

Trump's Executive Order on Marijuana Reclassification Sparks Mixed Reactions

Originally Published 24 days ago — by ABC News

Featured image for Trump's Executive Order on Marijuana Reclassification Sparks Mixed Reactions
Source: ABC News

President Trump signed an executive order reclassifying marijuana from Schedule I to Schedule III, aiming to facilitate medical research and reduce legal barriers, while not legalizing it federally. The move recognizes marijuana's potential medical benefits and seeks to improve research and medical access, but possession remains illegal under federal law.

Trump's Executive Order Reshapes Cannabis Policy and Industry Opportunities

Originally Published 24 days ago — by CNN

Featured image for Trump's Executive Order Reshapes Cannabis Policy and Industry Opportunities
Source: CNN

President Trump signed an executive order to expedite the reclassification of marijuana from Schedule 1 to Schedule 3, aiming to facilitate medical research and acknowledge potential medical benefits, though it stops short of full legalization or recreational reform. The move was influenced by lobbying from the cannabis industry and is seen as a symbolic first step, with ongoing barriers and debates about its implications and enforcement.

Bioinformatics Accelerates Development of Regenerative Therapies for Spinal Cord Injury

Originally Published 2 months ago — by Nature

Featured image for Bioinformatics Accelerates Development of Regenerative Therapies for Spinal Cord Injury
Source: Nature

Researchers identified thiorphan as a promising drug to promote neural regeneration and functional recovery after spinal cord injury by using a bioinformatics-driven pipeline, in vitro and in vivo testing, and validation in primate and human neurons, showing its potential for clinical translation.

Implant-Based Slow Release of Molecules to Prevent Glioblastoma Recurrence

Originally Published 2 months ago — by Nature

Featured image for Implant-Based Slow Release of Molecules to Prevent Glioblastoma Recurrence
Source: Nature

The article discusses a novel implantable wafer system called CANDI that delivers immunostimulatory small molecules to reprogram immunosuppressive myeloid cells in glioblastoma, leading to long-term survival and prevention of tumor recurrence in mouse models, with promising implications for human treatment.

Mapping Tumor Immune Niches in Diffuse Large B Cell Lymphoma

Originally Published 2 months ago — by Nature

Featured image for Mapping Tumor Immune Niches in Diffuse Large B Cell Lymphoma
Source: Nature

This study used spatial transcriptomics, proteomics, and genomics to analyze the tumor immune microenvironments in diffuse large B-cell lymphoma (DLBCL), identifying distinct cellular neighborhoods and communication patterns that influence immune cell function and tumor behavior, with implications for targeted immunotherapy.